Vor Biopharma’s Stock Soars as Telitacicept Shines in Sjögren’s Disease Study
Folks, hold onto your hats because Vor Biopharma (NASDAQ: VOR) is making waves in the market today, August 13, 2025, and for good reason! As of this writing, the stock is up a jaw-dropping 25% in pre-market trading, riding high on news that could shake up the world of autoimmune disease treatments. The catalyst? Their … Read more